Assessment of short-term changes induced by a Dermatophagoides pteronyssinus extract on asthmatic patients. Randomised, double-blind, placebo-controlled trial.

@article{Vidal2011AssessmentOS,
  title={Assessment of short-term changes induced by a Dermatophagoides pteronyssinus extract on asthmatic patients. Randomised, double-blind, placebo-controlled trial.},
  author={Carmen Vidal and Ana Isabel Tabar and Javier Figueroa and Jos{\'e} Antonio Dominguez Navarro and Ces{\'a}rea S{\'a}nchez and Agust{\'i}n Orovitg and Margarita Armis{\'e}n and Susana Echechip{\'i}a and Alejandro Joral and Susana Lizarza and Mar{\'i}a Teresa Lizaso and Virginia del Rosario Rodr{\'i}guez and Fernando de la Torre},
  journal={Current drug delivery},
  year={2011},
  volume={8 2},
  pages={152-8}
}
BACKGROUND Once the optimal dose is reached, subcutaneous immunotherapy [SCIT] with mite extract is capable of reducing symptoms and the need for rescue medication. OBJECTIVE To assess the capacity of a subcutaneous extract of mites [D. pteronyssinus] to bring about a reduction in concomitant medication as well as in vivo and in vitro changes in just 2-3 months of treatment in patients with allergic asthma. METHODS A total of 45 patients with persistent mild-moderate allergic asthma due to… CONTINUE READING